California, USA-based clinical-grade compliant Software-as-a-Service platform empowering life sciences professionals with the latest AI and computational techniques, Betteromics raised USD 20 million in Series A financing. The round took place on October 25, 2023. Sofinnova Partners and Triatomic Capital led the financing for the company. Meanwhile, SHAKTI joined in the funding.
Purpose of financing for Betteromics
With the latest financing, the company seeks to ramp up its hiring operations and expand the Betteromics team. It also has plans to scale marketing and sales efforts to life science companies, spanning startups to the largest enterprises.
What the company’s official has to add
Angela Lai, CEO and Founder of the company, said, “The industry has succeeded in finding ways to measure every omic and every analyte, but traditional methods and legacy systems have kept that data in silos, failing to unlock its immense potential. We’ve solved that.”
What the investors have to comment
Jeff Huber, Partner at Triatomic Capital, further said, “The most meaningful application of AI technology is in life sciences. The Betteromics team is uniquely positioned with their translational experience from building the lab, data, clinical, and machine learning platform that powered the largest clinical studies ever done to reduce risk and increase velocity from data generation to AI-powered insight for life sciences companies of all sizes.”
In addition, Edward Kliphuis, Partner at Sofinnova Partners, said, “Betteromics uniquely merges data science and human expertise in life sciences. The team brings together a rare combination of outstanding developers, data experts, and AI mavens with deep experience in the life sciences. Their groundbreaking approach to leveraging computational techniques on multi-omics datasets promises to bring unprecedented new insights and is poised to transform healthcare as we know it.”
About the company
Angela Lai in 2020 launched the company. Betteromics is on a mission to enable scientists, researchers, and clinicians to understand and gain insights from massive amounts of data leveraging advanced computation and AI techniques.
The company’s Omics AI Cloud platform eliminates data silos and further allows users to analyze multi-modal, multi-omics data in one place. It also reduces risk and increases velocity from data generation to AI-powered insights.
Betteromics platform is certified to ISO 9001 and ISO 27001, SOC2 Type II and HITRUST i1. Therefore, from day one, users can ensure traceability and reproducibility for all data and analysis performed, allowing clients to operate their data knowing there are rigorous protocols in place for their most valuable and sensitive data assets.
To explore more such startups, visit Zefyron Startup Database
For more extensive analysis and Market Intelligence reports, feel free to approach us.
We try our best to fact-check and bring well-researched as well as non-plagiarized content to you. Please let us know
if there are any discrepancies in any of our published stories,
-how we can improve,
-what stories you would like us to cover
–what information you are looking for in the comments section below or through our contact form! We look forward to your feedback, and thank you for stopping by!
Next Article
